Search

Displaying results 2911 - 2920 of 9132 in total
  1. Drug

    PRO 2000

    go.drugbank.com/drugs/DB05385
    Investigational

    PRO 2000 is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials.

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    CT103A

    go.drugbank.com/drugs/DB18180
    Investigational

    CT103A is an investigational BCMA-targeted genetically modified autologous T-cell immunotherapy.

  3. Drug

    CT120

    go.drugbank.com/drugs/DB18181
    Investigational

    CT120 is an investigational autologous CD19/22 targeted CAR-T cell immunotherapy.

  4. Drug

    Salanersen

    go.drugbank.com/drugs/DB18418
    Investigational

    BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.

  5. Drug

    AVX-470

    go.drugbank.com/drugs/DB18455
    Investigational

    AVX-470 is an anti-tumor necrosis factor (TNF) polyclonal antibody (bovine).

  6. Drug

    TTX-siPDL1

    go.drugbank.com/drugs/DB18550
    Experimental

    TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.

  7. Drug

    Gimatecan

    go.drugbank.com/drugs/DB06721
    Investigational

    Gimatecan is an orally available 7-t-butoxyiminomethyl-substituted lipophilic camptothecin derivative.

  8. Drug

    Nocodazole

    go.drugbank.com/drugs/DB08313
    Experimental

    Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.

  9. Drug

    Kebuzone

    go.drugbank.com/drugs/DB08940
    Investigational

    Kebuzone (also known as ketophenylbutazone ) is a non-steroidal anti-inflammatory drug.

  10. Drug

    Aminorex

    go.drugbank.com/drugs/DB01490
    ExperimentalIllicit

    Aminorex is an amphetamine-like anorectic agent. It may cause pulmonary hypertension.